GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest China

NCT01596868 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Squamous Cell Carcinoma
Toxicity Due to Radiotherapy

Interventions

DRUG: gemcitabine and cisplatin
DRUG: docetaxel and cisplatin

Sponsor

Air Force Military Medical University, China